SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020760
Filing Date
2018-08-09
Accepted
2018-08-09 08:06:39
Documents
56
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agle-10q_20180630.htm 10-Q 1742449
2 EX-10.1 agle-ex101_934.htm EX-10.1 128158
3 EX-31.1 agle-ex311_8.htm EX-31.1 16057
4 EX-31.2 agle-ex312_6.htm EX-31.2 15578
5 EX-32.1 agle-ex321_7.htm EX-32.1 7031
6 EX-32.2 agle-ex322_9.htm EX-32.2 6924
  Complete submission text file 0001564590-18-020760.txt   5494107

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT agle-20180630.xml EX-101.INS 1145627
8 XBRL TAXONOMY EXTENSION SCHEMA agle-20180630.xsd EX-101.SCH 39066
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agle-20180630_cal.xml EX-101.CAL 34488
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agle-20180630_def.xml EX-101.DEF 112015
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20180630_lab.xml EX-101.LAB 275088
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20180630_pre.xml EX-101.PRE 207342
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37722 | Film No.: 181003490
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences